Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival
|
|
- Della Logan
- 5 years ago
- Views:
Transcription
1 Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran, FRCS (C Th) Department of Cardiothoracic Surgery, St George s Hospital NHS Trust, London, United Kingdom Background. The primary objective was to estimate the risk of paraprosthetic regurgitation (PPR) after aortic (AVR) and mitral valve replacement (MVR) using interrupted (IN) or semicontinuous (SC) sutures. The secondary objective was to estimate the risk of redo valve surgery and 10-year survival after valve replacement performed using either suture technique. Methods. Patients who underwent mechanical AVR or MVR using a St. Jude prosthesis between December 1991 and June 1997 were included. Eighteen patients had MVR and 43 had AVR using IN sutures; 49 and 83 patients received MVR and AVR, respectively, using SC sutures. The majority of these patients were part of a randomized controlled trial with different end points, presented elsewhere. Patients were followed for 10 years with annual transthoracic echocardiography, and clinical data were collected retrospectively. Kaplan-Meier survival analysis was performed. Cox s regression analysis was performed to identify factors predicting mortality as a function of time. Forward stepwise logistic regression was performed to analyze risk factors predicting PPR. Mann-Whitney U test was used for continuous and nonparametric data, and 2 test and Fisher s exact test were used for categorical data. A probability value less than 0.05 was considered significant. Results. The overall risk of PPR after MVR and AVR was higher in the SC group than in the IN group. The need for redo AVR was significantly higher in the SC group. The suture technique did not affect the 10-year survival after either AVR or MVR. Conclusions. Use of SC technique increases the risk of significant PPR after AVR and MVR compared with IN technique independent of the size of prosthesis, degree of annular calcification, disease of the excised valve, or the implanting surgeon. Although 10-year survival is independent of suture technique, SC technique increases the risk of redo valve replacement after AVR. (Ann Thorac Surg 2010;89:1171 9) 2010 by The Society of Thoracic Surgeons Aortic (AVR) and mitral valve replacement (MVR) are performed using either semicontinuous (SC) or interrupted (IN) suture technique. The SC technique is quicker with shorter cross-clamp and cardiopulmonary bypass times [1]. Incidence of paraprosthetic regurgitation (PPR) detected by transesophageal echocardiography in the immediate postoperative period is about 10% to 15% after AVR and MVR, respectively [2]. Paraprosthetic regurgitation could lead to heart failure, hemolytic complications, and thromboembolic complications [3]. Factors considered contributory to PPR include the degree of annular calcification, infection, type of suture technique, and size and type of prosthesis [4, 5]. Hjelms and associates [6] demonstrated an increased risk of PPR after SC technique in patients who had AVR. Laks and colleagues [7] did not find any difference in the incidence of PPR between either suture technique, and Dhasmana and coworkers [5] have shown that in valve replacement for noninfective indications, suture technique did not predict PPR. None of these studies had long-term follow-up with regular echocardiograms. In this paper, we Accepted for publication Dec 30, Address correspondence to Dr Nair, Department of Cardiothoracic Surgery, Papworth Hospital NHS Trust, Cambridgeshire CB23 3RE, United Kingdom; sukumaran.nair@papworth.nhs.uk. report the incidence of PPR detected by annual echocardiograms after AVR and MVR by SC versus IN suture technique during a period of 10 years. Patients and Methods Patients younger than 70 years of age who underwent AVR or MVR using a St. Jude mechanical prosthesis between December 1991 and June 1997 were included. The majority of these patients were part of a randomized control trial investigating different end points. This randomized trial was approved by the institutional review board and the local research ethics committee and has been published before [8]. Echocardiographic and clinical data of patients who were not part of the randomized trial were obtained as part of routine clinical follow-up, and thus separate consent was not sought as individual patients are not identified. Data regarding PPR were collected and analyzed retrospectively. Inclusion and Exclusion Criteria Patients who received a St. Jude aortic or mitral prosthesis were included in the study. Patients who underwent valve replacement for active endocarditis and double valve disease were excluded. Two patients who died 2010 by The Society of Thoracic Surgeons /10/$36.00 Published by Elsevier Inc doi: /j.athoracsur
2 1172 NAIR ET AL Ann Thorac Surg SUTURE TECHNIQUE AND PARAPROSTHETIC REGURGITATION 2010;89: during surgery and 4 who died within the first month after surgery and who did not have PPR in their postoperative echocardiogram were also excluded. Patients with previous valve operations, treated endocarditis, and concomitant coronary artery disease were included. One patient in the aortic valve group was lost to follow-up after the first year and hence excluded from statistical analysis of long-term performance and survival but included in assessing the incidence of PPR. Study Groups Following the inclusion and exclusion criteria described above, 18 patients were identified in the mitral IN and 49 in the mitral SC group. Similarly, 43 patients were identified in the aortic IN and 83 in the aortic SC group. Operative Technique Five surgeons were involved in the implantation of these valves. The suture techniques adopted by individual surgeons were purely at their discretion. Surgeon C as identified in Table 4 used IN technique for all valve replacements. Continuous Suture Technique After excision of the diseased valve and thorough decalcification of the annulus, the annulus was sized and an appropriate-sized prosthesis used for implantation. None of the patients required enlargement of the aortic root for valve insertion. Continuous sutures were placed between the sewing ring of the prosthesis and the valve annulus, in both aortic and mitral positions using 2-0 Prolene (Ethicon, Somerville, NJ). Depending on the annular size and other technical aspects that emerged during the operation, the surgeon used two to four similar sutures with knots tied between them, hence the term semicontinuous. The valve was then parachuted down to the annulus, and the sutures were tied. Interrupted Technique Interrupted 2-0 Ethibond (Ethicon) polytetrafluoroethylene (Teflon) -buttressed sutures were used to suture the prosthesis-sewing ring to the annulus. All the patients had Teflon-buttresses positioned in the ventricular aspect of the annulus. Follow-Up Patients were followed up in a designated valve clinic on a yearly basis. Apart from detailed history and physical examination, patients underwent an electrocardiogram, chest radiograph, blood tests, and a transthoracic echocardiogram. The follow-up period was for a maximum of 10 years after valve implantation. One patient was lost to follow-up after the first postoperative year and hence excluded from statistical analysis. Patients with PPR observed in the transthoracic echocardiogram were discussed with the cardiologist, taking due consideration of all clinical variables to arrive at a consensus plan of action. In general terms, redo valve operation was performed if the PPR was graded as moderate or severe and conservative management was adopted if it was mild or trivial. Anticoagulation All patients were followed up in specialist anticoagulation clinics in general hospitals close to their place of residence where their international normalized ratio was checked and maintained between 3 and 4 for both aortic and mitral mechanical valves. Data Handling and Statistical Analysis Incidence of PPR at both aortic and mitral positions was recorded separately. Kaplan-Meier survival analysis was performed to study the trend in the survival of patients who had their valves replaced using either suture technique. Mann-Whitney U test was used for continuous variables and nonparametric data among patients in the two groups. 2 test and Fisher s exact test were used to study any difference between the two groups for categorical or dichotomous data. Cox s regression analysis was performed to identify factors predictive of survival after valve replacement. For this analysis, demographic factors, namely age, sex, disease of the native valve (predominantly regurgitant or stenotic), and diabetes mellitus; preoperative factors, namely left ventricular ejection fraction, diabetes mellitus, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, body surface area, cardiothoracic ratio, New York Heart Association class, healed endocarditis, and rhythm; operative variables, namely suture material used, suture technique, valve or prosthesis size, annular calcification, and concomitant coronary artery bypass grafts performed; and postoperative variables, namely incidence of PPR, grade of PPR, and interval between surgery and detection of PPR, were considered as independent outcomes. Forward stepwise logistic regression was performed to analyze risk factors responsible for the occurrence of PPR after valve replacement. Independent factors considered were age, sex, New York Heart Association class, annular calcification, diabetes mellitus, concomitant coronary artery bypass grafting, preoperative rhythm, disease of the native valve, suture technique used, body surface area, and the surgeon performing the operation. A probability value less than 0.05 was considered significant, accepting a confidence interval of 95%. The statistical program SPSS 14.0 (SPSS, Chicago, IL) was used for the various analyses. Results Patient Characteristics Patients were divided into the SC or IN groups. Among the MVR group (Table 1), 41 were women (61%) and 26 were men (39%). Both groups were comparable in terms of disease of the valve, size of prosthesis, body mass index, age, preoperative left ventricular function, cardiothoracic ratio, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, or annular calcifica-
3 Ann Thorac Surg NAIR ET AL 2010;89: SUTURE TECHNIQUE AND PARAPROSTHETIC REGURGITATION 1173 Table 1. Distribution of Categorical Variables Among Patients Who Underwent Mitral Valve Replacement Variable SC IN Total p Value Median age and 65 (41 77) 64 (32 70) 0.38 range (y) Sex Female Male Diagnosis Predominantly stenotic Predominantly regurgitant Rhythm Sinus Other NYHA grade IorII III IV LVEF Treated endocarditis No Yes SJ valve size (mm) CABG No Yes Mitral annular calcification No Yes Median LVEDD (1st, 5.5 (5.1, 6.1) 5.7 (4.8, 6.3) rd quartile) Median LVESD (1st, 3rd quartile) 3.7 (3.1, 4.2) 3.5 (2.9, 4.4) 0.99 CABG coronary artery bypass grafts; IN interrupted technique; LVEDD left ventricular end-diastolic diameter in cm; LVEF left ventricular ejection fraction; LVESD left ventricular end-systolic diameter in cm; NYHA New York Heart Association; SC semicontinuous technique; SJ valve St. Jude valve. tion. The incidence of simultaneous coronary artery bypass grafting was significantly more in the SC group. In the AVR group (Table 2), 100 patients were men (79.4%) and 26 were women (20.6%). The groups did not differ from each other in terms of valvular disease, size of prosthesis, body mass index, age, preoperative left ventricular function, cardiothoracic ratio, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, annular calcification, or concomitant coronary artery bypass graft surgery. Risk of Paraprosthetic Regurgitation Persists Beyond the First Year After Valve Replacement After MVR, the median number of postoperative days at which PPR was detected in the IN and SC group was 887 days (range, 733 to 1,040 days) and 515 days (range, 7 to 1,831 days), respectively (p 0.56). After AVR, the median number of postoperative days at which PPR was detected in the IN and SC group was 206 days (range, 35 Table 2. Distribution of Categorical Variables Among Patients Who Underwent Aortic Valve Replacement Variable SC IN Total p Value Median age and 63 (28 74) 62 (46 76) 0.83 range (y) Sex Female Male Diagnosis Predominantly stenotic Predominantly regurgitant Rhythm Sinus Other NYHA grade IorII III IV LVEF Treated endocarditis No Yes SJ valve size (mm) CABG No Yes Aortic annular calcification No Yes Median LVEDD (1st, 5.5 (4.7, 6.4) 5.3 (5.0, 6.3) rd quartile) Median LVESD (1st, 3rd quartile) 3.6 (2.9, 4.6) 3.4 (3.0, 4.8) 0.95 CABG coronary artery bypass grafts; IN interrupted technique; LVEDD left ventricular end-diastolic diameter in cm; LVEF left ventricular ejection fraction; LVESD left ventricular end-systolic diameter in cm; NYHA New York Heart Association; SC semicontinuous technique; SJ valve St. Jude valve.
4 1174 NAIR ET AL Ann Thorac Surg SUTURE TECHNIQUE AND PARAPROSTHETIC REGURGITATION 2010;89: Table 3. Incidence, Relative Risk, and Management of Paraprosthetic Regurgitation After Mitral Valve Replacement and Aortic Valve Replacement Using Different Suture Techniques Details of PPR SC IN Total 2 Two- Sided Test MVR group Surgical significance of PPR Absent mild PPR Moderate severe PPR Relative risk, 1.51; 95% CI, 1.25 to 1.84 Management of PPR after MVR Conservative Redo valve replacement AVR group Surgical significance of PPR Absent mild PPR Moderate severe PPR Relative risk, 1.59; 95% CI, 1.38 to 1.83 Management of PPR after AVR Conservative Redo valve replacement Relative risk, 2.0; 95% CI, 1.14 to 3.52 AVR aortic valve replacement; CI confidence interval; IN interrupted technique; MVR mitral valve replacement; PPR periprosthetic regurgitation; SC semicontinuous technique. to 1,430 days) and 557 days (range, 0 to 1,586 days), respectively (p 0.51). Risk to develop PPR persists beyond the first year after valve replacement. Semicontinuous Suture Technique Increases the Risk of Significant Paraprosthetic Regurgitation but Did Not Affect the Rate of Reoperation or 10-Year Survival After Mechanical Mitral Valve Replacement The relative risk to develop any degree of PPR after mechanical MVR with SC technique was 3.31 (95% confidence interval, 0.85 to 12.85). The incidence of moderate or severe PPR after MVR using the IN technique was 0% (0 of 18 patients) compared with 28.6% (14 of 49 patients) after SC technique (Table 3). This difference was statistically significant (p 0.01), giving a relative risk of 1.51 (95% confidence interval, 1.25 to 1.84) to develop significant PPR (moderate or severe) with SC technique. Figure 1 demonstrates a statistically significant increase in the incidence of PPR when MVR was performed using SC technique. In this study it did not translate into an increase in redo MVR in the SC group. This reflects case selection bias by the surgeons in surgical intervention when PPR was detected. The 10-year survival of patients who underwent MVR using either technique was similar (Fig 2). Semicontinuous Suture Technique Increases the Risk of Significant Paraprosthetic Regurgitation and Need for Reoperation After Mechanical Aortic Valve Replacement With No Significant Difference in 10-Year Survival The incidence of moderate or severe PPR after mechanical AVR using the IN technique was 0% (0 of 43 patients) compared with 12% (10 of 83 patients) after SC technique (Table 3). This difference was statistically significant (p 0.02), giving a relative risk of 1.59 (95% confidence interval, 1.38 to 1.83) to develop clinically significant PPR (moderate and severe PPR) with SC technique. The Table 4. Regression Analysis of Factors Predicting Survival With Time and Incidence of Paraprosthetic Regurgitation After Mitral Valve Replacement and Aortic Valve Replacement Variable Coefficient SEM Wald df p Value Exp(coef) 95% CI 2 df p Value MVR Cox s regression for survival with time Age LVEF Forward stepwise logistic regression for PPR Surgeon C Constant AVR Cox s regression for survival with time Age Nonsinus rhythm Redo for PPR Forward stepwise logistic regression for PPR Annular calcification Constant AVR aortic valve replacement; CI confidence interval; df degrees of freedom; Exp(coef) exponential coefficient; LVEF left ventricular ejection fraction; MVR mitral valve replacement; PPR periprosthetic regurgitation; SEM standard error of the mean.
5 Ann Thorac Surg NAIR ET AL 2010;89: SUTURE TECHNIQUE AND PARAPROSTHETIC REGURGITATION 1175 Fig 1. Effect of suture technique on survival after mitral valve replacement (MVR). Kaplan-Meier survival curves demonstrating postoperative survival are shown with years on the x axis and the y axis representing percentage survival. The dotted line represents the interrupted technique (IN) suture group and the continuous line represents the semicontinuous technique (SC) suture group. Table of patients at risk of death is shown below the survival curves. relative risk of redo valve replacement owing to significant PPR after SC technique was 2.0 (95% confidence interval, 1.14 to 3.52). Significantly more patients required reoperation to treat significant PPR in the SC group compared with the patients in the IN group (p 0.02). Figure 3 demonstrates that most of the reoperations occurred within the first 4 postoperative years, after which the incidence of PPR after AVR was not statistically different between the groups. Although the SC suture technique increased the risk of PPR and redo valve replacements, it did not affect the 10-year survival rate after AVR (Fig 4). Predictors of Survival With Time and Incidence of Paraprosthetic Regurgitation After Valve Replacement Cox regression analysis revealed that after MVR, the age of the patient and impaired left ventricular function predict mortality as a function of time (Table 4). Forward stepwise regression analysis showed that surgeon C, who always used the IN technique, prevented PPR after MVR. After AVR, the age of the patient, nonsinus rhythm (atrial fibrillation or pacemaker rhythm), and redo valve replacement predicted mortality as a function of time (Table 4). Annular calcification was the only significant predictor of PPR after AVR. Comment Paraprosthetic regurgitation is a serious complication after valve replacement operations [2, 3]. In the past, PPR was diagnosed only when patients presented with symptoms of valve regurgitation, heart failure, infective complications, or hemolysis [3, 9]. Nowadays, with the ready availability of echocardiograms, even trivial PPR is detected, probably explaining the 15% incidence in the modern era [2]. Our study specifically looked into the difference in incidence of mild, moderate, or severe PPR in patients who underwent mechanical MVR and AVR using two different suture techniques.
6 1176 NAIR ET AL Ann Thorac Surg SUTURE TECHNIQUE AND PARAPROSTHETIC REGURGITATION 2010;89: Fig 2. Effect of suture technique on survival after aortic valve replacement (AVR). Kaplan-Meier survival curves demonstrating postoperative survival are shown with years on the x axis and the y axis representing percentage survival. The dotted line represents the interrupted technique (IN) suture group and the continuous line represents the semicontinuous technique (SC) suture group. Table of patients at risk of death is shown below the survival curves. Ionescu and colleagues [2] demonstrated that PPR occurs in 6% and 32% of AVR and MVR, respectively. In their study, 6 months after surgery only 56% of patients agreed for a second transesophageal echocardiogram, and the incidence of PPR recorded was 10% and 15% after AVR and MVR, respectively. Two thirds of the aortic and one fifth of the mitral PPR detected at 6 months were new. They also found that the incidence of PPR was more in aortic valves inserted in the supraannular compared with intraannular position, and in the case of mitral valves, when SC suture technique was used compared with IN technique. In this study, PPR was not quantified or graded. None of their patients with PPR underwent reoperation. They concluded that PPR did not affect outcome in a 9-month follow-up period after valve replacement, despite the fact that many of the PPR jets identified at 6 months follow-up were new [2]. Clearly this study did not assess the incidence of PPR in the medium or long-term nor did they grade or quantify the PPR when diagnosed either immediately after surgery or after 6 months. In our study, we have shown that the incidence of mild, moderate, and severe PPR is significantly more after both AVR and MVR when SC suture technique was used compared with IN technique during a 10-year follow-up period. After AVR and MVR, PPR was detected at a median of 378 days (range, 0 to 1,586 days) and 664 days (range, 7 to 1,831 days), respectively. This clearly demonstrates that the risk of developing PPR persists beyond the first year after valve replacement. This observation suggests that annual echocardiograms are important in the follow-up after valve replacement for early diagnosis and timely intervention for PPR. Patients who had AVR and MVR were similar in age, sex distribution, annular calcification, preoperative New York Heart Association grade, left ventricular ejection fraction, valve disease, and left ventricular dimensions. Patients who underwent MVR more-often required concomitant coronary artery bypass grafting compared with those who had their valves replaced using IN sutures. The fact that SC suturing is quicker than IN suture technique might have influenced the surgeons choice of suture technique in combined valve and graft procedures. In subsequent analysis using log-rank (Mantel- Cox) test, we have demonstrated that concomitant coronary artery bypass grafting did not affect survival of
7 Ann Thorac Surg NAIR ET AL 2010;89: SUTURE TECHNIQUE AND PARAPROSTHETIC REGURGITATION 1177 Fig 3. Effect of suture technique on incidence of periprosthetic regurgitation (PPR) after mitral valve replacement (MVR). Graphs represent freedom from periprosthetic regurgitation with different suture techniques. The dotted line represents the interrupted technique (IN) suture group and the continuous line represents the semicontinuous technique (SC) suture group. Table of patients at risk of periprosthetic regurgitation is shown below the curves. patients after either MVR (p 0.74) or AVR (p 0.29; illustrations not included). All patients in our study who had clinically significant PPR (moderate or severe degree) belonged to the SC suture group, irrespective of whether they had AVR or MVR. In our study, SC technique increased the risk of PPR and redo valve surgery after AVR, compared with IN suture technique. Although the incidence of PPR after MVR using the SC suture technique was significantly higher than in the IN suture group, it did not lead to a significant increase in redo valve replacements. This might be related to the inherent reluctance among surgeons to surgically intervene in this high-risk group of patients. Long-term survival after either AVR or MVR was not affected by the type of suture technique used. We further analyzed our data to study whether redo surgery alone increased the risk of mortality in these patients using log-rank (Mantel-Cox) test. This showed that redo valve replacement alone did not affect survival of patients after either MVR (p 0.67) or AVR (p 0.13; illustrations not included). Previous studies have shown timely surgical intervention reduces mortality in significant PPR [4]. We thus would recommend redo valve replacement in clinically significant PPR as the risk of redo valve replacement is relatively insignificant. In our series, Cox regression analysis showed that the predictors of mortality in time after MVR were age of the patient and impaired left ventricular function. Forward stepwise logistic regression of our data showed surgeon C (who always used the IN suture technique) to prevent PPR. Among AVR patients, age, nonsinus rhythm, and redo valve replacement for PPR were predictors of mortality in time. Both suture techniques discussed in this paper have advantages and disadvantages. We believe that the major disadvantage of the SC technique is the increased risk of significant PPR, which continues beyond the first year after surgery. Attention to detail during operation and selective use of SC technique should help in reducing this risk. The advantage of SC technique might be its association with a shorter cross-clamp time, and thus it
8 1178 NAIR ET AL Ann Thorac Surg SUTURE TECHNIQUE AND PARAPROSTHETIC REGURGITATION 2010;89: Fig 4. Effect of suture technique on incidence of periprosthetic regurgitation (PPR) after aortic valve replacement (AVR). Graphs represent freedom from periprosthetic regurgitation with different suture techniques. The dotted line represents the interrupted technique (IN) suture group and the continuous line represents the semicontinuous technique (SC) suture group. Table of patients at risk of periprosthetic regurgitation is shown below the curves. might have benefit in patients with poor left ventricular function. Limitations of the Study Although this study is retrospective in nature, the data including echocardiogram details were collected in a prospective fashion. The suture technique was the operating surgeons choice. The decision to reoperate on symptomatic patients with PPR was made after consultation between the surgeon and cardiologist, taking the clinical urgency into consideration. We have not made comparison between survival with or without redo valve replacement as the numbers in the latter group were few. Being a retrospective study, we could not analyze the incidence or severity of hemolysis associated with PPR. Paraprosthetic regurgitation was quantified purely based on symptoms and annual transthoracic echocardiograms performed. Even though not a randomized group, these data represent the actual situation of PPR after valve replacement. Another limitation of this study is the fact that 5 surgeons were involved in these operations. Detailed statistical analysis failed to show that individual surgeons were independent risk factors for the incidence of PPR. Conclusions Incidence of PPR is significantly more when AVR or MVR is performed using SC technique compared with the IN suture technique. This results in a higher rate of redo valve replacements, particularly after AVR. Thus, SC technique should only be used realizing the increased risk of PPR and its subsequent effect on the prognosis of patients. We wish to thank Andrew Murday, FRCS, Professor Tom Treasure, FRCS, John Smith, FRCS, and the late John Parker, FRCS, for organizing the trial originally from which many patients were included in this analysis. We also wish to acknowledge financial support for part of the study from St. Jude Medical UK, Ltd, and Edwards Lifesciences, Ltd, for providing financial support in the organization of the randomized trial that later contributed to many patients included in this retrospective study.
9 Ann Thorac Surg NAIR ET AL 2010;89: SUTURE TECHNIQUE AND PARAPROSTHETIC REGURGITATION 1179 References 1. Qicai H, Zili C, Zhengfu H, et al. Continuous-suture technique in aortic valve replacement. J Card Surg 2006;21: Ionescu A, Fraser A, Butchart E. Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesphageal echocardiography. Heart 2003;89: Kloster F. Diagnosis and management of complications of prosthetic heart valves. Am J Cardiol 1975;35: Genoni M, Franzen D, Vogt P, et al. Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery? Eur J Cardiothorac Surg 2000;17: Dhasmana J, Blackstone E, Kirklin J, Kouchoukos N. Factors associated with periprosthetic leakage following primary mitral valve replacement. With special consideration of the suture technique. Ann Thorac Surg 1983;35: Hjelms E, Vilhelmsen R, Rygg T. Continuous suture technique in prosthetic aortic valve replacement. J Cardiovascular Surg 1982;23: Laks H, Pearl J, Barthei S. Aortic valve replacement using a continuous suture technique. J Card Surg 1993;8: Murday AJ, Hochstitzky A, Mansfield J, et al. A prospective controlled trial of St. Jude versus Starr Edwards aortic and mitral valve prostheses. Ann Thorac Surg 2003;76: Rodgers B, Sabiston D. Hemolytic anemia following prosthetic valve replacement. Circulation 1969;39: Notice From the American Board of Thoracic Surgery The 2010 Part I (written) examination will be held on Monday, November 22, It is planned that the examination will be given at multiple sites throughout the United States using an electronic format. The closing date for registration is August 15, Those wishing to be considered for examination must apply online at To be admissible to the Part II (oral) examination, a candidate must have successfully completed the Part I (written) examination. A candidate applying for admission to the certifying examination must fulfill all the requirements of the Board in force at the time the application is received. Please address all communications to the American Board of Thoracic Surgery, 633 N St. Clair St, Suite 2320, Chicago, IL 60611; telephone: (312) ; fax: (312) ; info@abts.org by The Society of Thoracic Surgeons Ann Thorac Surg 2010;89: /10/$36.00 Published by Elsevier Inc
Experience with 500 Stentless Aortic Valve Replacements
Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationLate secondary TR after left sided heart disease correction: is it predictibale and preventable
Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationInfluence of Atrial Fibrillation on Outcome Following Mitral Valve Repair
Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Eric Lim, MBChB, MRCS; Clifford W. Barlow, DPhil, FRCS; A. Reza Hosseinpour, FRCS; Christopher Wisbey, BA; Kate Wilson, RN, BSc;
More informationAlthough mitral valve replacement (MVR) is no longer the surgical
Surgery for Acquired Cardiovascular Disease Ruel et al Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves Marc Ruel, MD, MPH a,b Fraser D.
More informationThe operative mortality rate after redo valvular operations
Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationPersistent Tricuspid Regurgitation After Tricuspid Annuloplasty During Redo Valve Surgery Affects Late Survival and Valve-Related Events
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Advance Publication by-j-stage Persistent Tricuspid Regurgitation After Tricuspid Annuloplasty During Redo
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationHani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.
Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility
More informationResults of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency
Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Ken-ichi ASANO, M.D., Masahiko WASHIO, M.D., and Shoji EGUCHI, M.D. SUMMARY (1) Surgical results of
More informationCarpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience
SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationSurgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan
Surgical AF Ablation : Lesion Sets and Energy Sources What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan Disclosures Consultant/Advisory Board: Abbott, Edwards Lifesciences
More informationKinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands
Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart
More informationEchocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Original Article
Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Abstract Arezoo Khosravi (1), Hadi Sheykhloo (2), Reza Karbasi-Afshar (1), Amin Saburi (3) Original
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationSevere left ventricular dysfunction and valvular heart disease: should we operate?
Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict
More informationClinical material and methods. Fukui Cardiovascular Center, Fukui, Japan
Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationThe Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More informationIschemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications
Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo
More informationTHE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT
THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT Gideon Cohen, MD Tirone E. David, MD Joan Ivanov, MSc Sue Armstrong, MSc
More informationMitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John
More informationClinical material and methods. Copyright by ICR Publishers 2003
Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and
More informationDurability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement
Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement Masaki Hamamoto, MD, Ko Bando, MD, Junjiro Kobayashi, MD, Toshihiko Satoh, MD, MPH, Yoshikado
More informationRepeated mitral valve replacement in a patient with extensive annular calcification
CASE REPORT Open Access Repeated mitral valve replacement in a patient with extensive annular calcification Tadashi Kitamura 1,2*, Sachito Fukuda 1, Takahiro Sawada 1, Sumio Miura 1, Ikutaro Kigawa 1,3
More informationDe Vega Annuloplasty for Functional Tricupsid Regurgitation: Concept of Tricuspid Valve Orifice Index to Optimize Tricuspid Valve Annular Reduction
ORIGINAL ARTICLE Cardiovascular Disorders http://dx.doi.org/10.3346/jkms.2013.28.12.1756 J Korean Med Sci 2013; 28: 1756-1761 De Vega Annuloplasty for Functional Tricupsid Regurgitation: Concept of Tricuspid
More informationRole of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic,
Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic, transplantation and Vascular Surgery Hannover Medical School, Germany
More informationIncidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves
INTERVENTION/VALVULAR HEART DISEASE ORIGINAL ARTICLE Cardiology Journal 2016, Vol. 23, No. 2, 178 183 DOI: 10.5603/CJ.a2016.0011 Copyright 2016 Via Medica ISSN 1897 5593 Incidence of prosthesis-patient
More informationJournal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 44, 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.062 Relation
More informationORIGINAL PAPER. The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan
Nagoya J. Med. Sci. 78. 369 ~ 376, 2016 doi:10.18999/nagjms.78.4.369 ORIGINAL PAPER The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan
More informationLong-Term Results With the Medtronic-Hall Valvular Prosthesis
Long-Term Results With the Medtronic-Hall Valvular Prosthesis Cary W. Akins, MD Cardiac Surgical Unit, Massachusetts General Hospital, Boston, Massachusetts Background. Although more than 170,000 Medtronic-
More informationDisclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech
Disclosures ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Speaker s fee Edwards Lifesciences Sanofi-Aventis Decision Making in Patients with Multivalvular
More informationIndication, Timing, Assessment and Update on TAVI
Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical
More informationThe risk-benefit ratio of mitral valve operation is
Degenerative Mitral Regurgitation: When Should We Operate? Malcolm J. R. Dalrymple-Hay, PhD, Mark Bryant, Richard A. Jones, MRCP, Stephen M. Langley, FRCS, Steven A. Livesey, FRCS, and James L. Monro,
More informationQuality Outcomes Mitral Valve Repair
Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding
More informationRe-do aortic valve replacement after previous homograft aortic root replacement
Re-do aortic valve replacement after previous homograft aortic root replacement Jullien Gaer, Toufan Bahrami, Fabio de Robertis, Ahmed Abdulsalam, John Pepper, NHS Foundation Trust, UK Professor Sir Magdi
More informationClinical material and methods. Copyright by ICR Publishers 2007
16847_JHVD_Biancari_3197_(116-121)_r1:Layout 1 21/3/07 17:07 Page 116 Predicting Immediate and Late Outcome after Surgery for Mitral Valve Regurgitation with EuroSCORE Jouni Heikkinen, Fausto Biancari,
More informationRepair or Replacement
Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationThe CarboMedics prosthetic valve (Sulzer CarboMedics,
Long-Term Result of 1144 CarboMedics Mechanical Valve Implantations Chang Hyun Kang, MD, Hyuk Ahn, MD, Kyung Hwan Kim, MD, and Ki-Bong Kim, MD Department of Thoracic and Cardiovascular Surgery, Seoul National
More informationRisk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects
Korean J Thorac Cardiovasc Surg 2017;50:78-85 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) CLINICAL RESEARCH https://doi.org/10.5090/kjtcs.2017.50.2.78 Risk Analysis of the Long-Term Outcomes of the
More informationMedtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance
Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance W. R. Eric Jamieson, MD, a Friedrich-Christian Riess, MD, b Peter J. Raudkivi, MD, c Jacques Metras, MD, d Edward F. G. Busse,
More informationIncidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Ömer Aktug 1, MD; Guido Dohmen 2, MD; Kathrin Brehmer 1, MD; Verena Deserno 1 ; Ralf Herpertz 1 ; Rüdiger
More informationEchocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis
The Egyptian Heart Journal (2013) 65, 135 139 Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Echocardiographic variables associated
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationReoperations after primary aortic valve replacement
Third-Time Aortic Valve Replacement: Patient s and Operative Outcome Kasra Shaikhrezai, MD, MRCS, Giordano Tasca, MD, FETCS, Mohamed Amrani, PhD, FETCS, Gilles Dreyfus, MD, FETCS, and George Asimakopoulos,
More informationAortic valve implantation using the femoral and apical access: a single center experience.
Aortic valve implantation using the femoral and apical access: a single center experience. R. Hoffmann, K. Brehmer, R. Koos, R. Autschbach, N. Marx, G. Dohmen Rainer Hoffmann, University Aachen, Germany
More informationTranscatheter Aortic Valve Implantation in Patients With Concomitant Mitral and Tricuspid Regurgitation
Transcatheter Aortic Valve Implantation in Patients With Concomitant Mitral and Tricuspid Regurgitation Andrea Hutter, MD, Sabine Bleiziffer, MD, PhD, Valerie Richter, MS, Anke Opitz, MD, Ina Hettich,
More informationThe St. Jude Medical Biocor Bioprosthesis
The St. Jude Medical Biocor Bioprosthesis Clinical Evidence of Long-term Durability Long-term Biocor Experience A Review and Comparative Assessment Long-term Biocor Stented Tissue Valve Studies Twenty-year
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationMitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia
Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties
More informationClinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years
Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP, FACC, a Jose L. Pomar, MD, PhD, FETCS, b Carlos A. Mestres,
More informationInfluence of patient gender on mortality after aortic valve replacement for aortic stenosis
Influence of patient gender on mortality after aortic valve replacement for aortic stenosis Jennifer Higgins, MD, W. R. Eric Jamieson, MD, Osama Benhameid, MD, Jian Ye, MD, Anson Cheung, MD, Peter Skarsgard,
More informationDevelopment of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations
Imaging and Diagnostic Testing Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Jae-Jin Kwak, MD, a Yong-Jin
More informationReally Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?
Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? David H. Adams, MD Cardiac Surgeon-in-Chief Mount Sinai Health System Marie Josée and Henry R. Kravis Professor and
More information164 Ann Thorac Surg 45: , Feb Copyright by The Society of Thoracic Surgeons
Heart Valve Replacement with the Bjork-Shiley Mbnostrut Valve: Early Results of a Multicenter Clinical Investigation Lars I. Thulin, M.D., William H. Bain, F.R.C.S., Hans H. Huysmans, M.D., Gerrit van
More informationPara-valvular Leak Closure
Para-valvular Leak Closure Antonios Halapas, MD, PhD, FESC THV & Hygeia Hospital Heart Team Athens, Greece Disclosures I and the HYGEIA Hospital «Heart Team» have received research and travel grants from
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationHaiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction
Original Article Comparison of outcomes of tricuspid annuloplasty with 3D-rigid versus flexible prosthetic ring for functional tricuspid regurgitation secondary to rheumatic mitral valve disease Haiping
More informationTAVR: Echo Measurements Pre, Post And Intra Procedure
2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate
More informationMid-term results in patients having tricuspidization of the quadricuspid aortic valve
Song et al. Journal of Cardiothoracic Surgery 2014, 9:29 RESEARCH ARTICLE Open Access Mid-term results in patients having tricuspidization of the quadricuspid aortic valve Meong Gun Song 1, Hyun Suk Yang
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationTAVI Versus Suturless Valve In Intermediate Risk Patients
TAVI Versus Suturless Valve In Intermediate Risk Patients Walid Abukhudair FRCSc President of Saudi Society for Cardiac Surgeons Head of Cardiac Surgery in KFAFH Background AS is the most frequent cardiac
More informationThe increase in the lifespan of the western population
Outcome After Aortic Valve Replacement in Octogenarians Bruno Chiappini, MD, Nicola Camurri, MD, Antonio Loforte, MD, Luca Di Marco, MD, Roberto Di Bartolomeo, MD, and Giuseppe Marinelli, MD Department
More informationDepartment of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden
Long-Term Outcome of the Mitroflow Pericardial Bioprosthesis in the Elderly after Aortic Valve Replacement Johan Sjögren, Tomas Gudbjartsson, Lars I. Thulin Department of Cardiothoracic Surgery, Heart
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationSurgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse
Surgery for Valvular Heart Disease Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Dania Mohty, MD; Thomas A. Orszulak, MD; Hartzell V. Schaff, MD; Jean-Francois
More informationTranscatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data
Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,
More informationHow to Avoid Prosthesis-Patient Mismatch
How to Avoid Prosthesis-Patient Mismatch Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE, FESC Canada Research Chair in Valvular Heart Diseases INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationFactors Associated With Periprosthetic Leakage Following Primary Mtral Vave ReplacemenE With Special Consideration of the Suture Technique
Factors Associated With Periprosthetic Leakage Following Primary Mtral Vave ReplacemenE With Special Consideration of the Suture Technique Janardan P. Dhasmana, M.B., F.R.C.S., Eugene H. Blackstone, M.D.,
More informationEarly Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study
Early Experience of Transcatheter Mitral Valve Replacement Results from the Paul Sorajja, MD for the Investigators Presenter Disclosure Information Within the past 12 months, I or my spouse/partner have
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationOutcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era
Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era Sebastian A. Iturra, Rakesh M. Suri, Kevin L. Greason, John
More informationWhich Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?
Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should
More informationAortic Valve Practice Guidelines: What Has Changed and What You Need to Know
Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts
More informationHeart valve replacement with the Bjork-Shiley and St Jude Medical prostheses: A randomized comparison in 178 patients
European Heart Journal (1990) 11, 583-591 Heart valve replacement with the Bjork-Shiley and St Jude Medical prostheses: A randomized comparison in 178 patients S. VOGT, A. HOFFMANN, J. ROTH, P. DUBACH,
More informationHemodynamics and Early Clinical Performance of the St. Jude Medical Regent Mechanical Aortic Valve
Hemodynamics and Early Clinical Performance of the St. Jude Medical Regent Mechanical Aortic Valve David S. Bach, MD, Marc P. Sakwa, MD, Martin Goldbach, MD, Michael R. Petracek, MD, Robert W. Emery, MD,
More informationLong term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation
Featured Article Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Igor Gosev 1, Maroun Yammine 1, Marzia Leacche 1, Siobhan McGurk 1, Vladimir Ivkovic 1, Michael
More informationΧειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας
Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation
More information(Ann Thorac Surg 2008;85:845 53)
I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable
More informationPermanent Pacemaker Implantation After Isolated Aortic Valve Replacement: Incidence, Indications, and Predictors
Permanent Pacemaker Implantation After Isolated Aortic Valve Replacement: Incidence, Indications, and Predictors Sam Dawkins, MB BS, Alex R. Hobson, MB BS, Paul R. Kalra, MD, Augustine T. M. Tang, DM,
More informationPPM: How to fit a big valve in a small heart
PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationMitral Valve Repair at King Chulalongkorn Memorial Hospital; A Preliminary Report.
Mitral Valve Repair at King Chulalongkorn Memorial Hospital; A Preliminary Report. Jiranut Cholteesupachai, MD.*, Smonporn Boonyaratavej Songmuang, MD.*, Seri Singhatanadgige, MD. ** King Chulalongkorn
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationPercutaneous mitral valve repair: current techniques and results
Percutaneous mitral valve repair: current techniques and results Ted Feldman, M.D., FSCAI, FACC Angioplasty Summit April 25-27 th th 2007 Seoul, Korea Ted Feldman MD, FACC, FSCAI Disclosure Information
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationPROSTHETIC VALVE BOARD REVIEW
PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve
More informationNew-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery
New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery Giovanni Filardo, PhD, MPH, Cody Hamilton, PhD, Baron Hamman, MD, Robert F. Hebeler, Jr, MD, John
More informationValvular heart disease (VHD) is present in 2.5% of the
2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations Richard Matiasz, MD; Vera H. Rigolin, MD Valvular heart disease (VHD) is present in 2.5% of the
More informationReconstruction of the intervalvular fibrous body during aortic and
Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,
More information